WASHINGTON – With the robust participation of Americans nationwide, DEA and its law enforcement partners have now surpassed its 10 million pound goal and collected nearly 11 million pounds of unused, unwanted or expired prescription medications over the course of 16 successful DEA National Prescription Drug Take Back events. During...

NEW YORK - Raymond P. Donovan, the Special Agent in Charge of the DEA Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York announced that Baktash Akasha Abdalla, aka “Baktash Akasha,” and Ibrahim Akasha Abdalla, aka “Ibrahim Akasha,” pled guilty yesterday...

WASHINGTON – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming fall 2018...

WASHINGTON – The United States Drug Enforcement Administration is gearing up to kick off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort, which launches October 23. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in...

WASHINGTON – The United States of America, through its Departments of Justice, Treasury, and State announced today a series of measures to target and dismantle the Cartel Jalisco Nueva Generacion (CJNG) – one of the largest, most dangerous drug cartels currently operating in Mexico. These measures include the unsealing of...

SALT LAKE CITY – DEA Acting Administrator Uttam Dhillon today highlighted the significance of law enforcement as part of a successful, comprehensive solution to the opioid epidemic, stressing efforts aimed at those supplying communities with deadly, addictive drugs. Acting Administrator Dhillon delivered remarks to hundreds of medical practitioners, drug treatment...

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...

NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...